Work will include supporting trial sponsors and facilitating dialogue among patients, professionals and academia
An initiative to improve how clinical trials are carried out in the EU has published a 2022-26 work plan setting out details of forthcoming activities.
Launched in January by the European Commission, European Medicines Agency and Heads of Medicines Agencies, the Accelerating Clinical Trials in the EU initiative aims to improve trial initiation, design and execution.